BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 164475)

  • 21. Bromodeoxyuridine dependence--a new mutation in mammalian cells.
    Davidson RL; Bick MD
    Proc Natl Acad Sci U S A; 1973 Jan; 70(1):138-42. PubMed ID: 4509645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel phenotypes arising from selection of hamster melanoma cells for resistance to BUdR.
    Kaufman ER; Davidson RL
    Exp Cell Res; 1977 Jun; 107(1):15-24. PubMed ID: 558895
    [No Abstract]   [Full Text] [Related]  

  • 23. Cell kinetics of rat 9L brain tumors determined by double labeling with iodo- and bromodeoxyuridine.
    Asai A; Shibui S; Barker M; Vanderlaan M; Gray JW; Hoshino T
    J Neurosurg; 1990 Aug; 73(2):254-8. PubMed ID: 2366082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of rRNA synthesis following incorporation of 5-bromodeoxyuridine into DNA of Tetrahymena pyriformis.
    Lykkesfeldt AE; Andersen HA
    J Cell Sci; 1975 May; 17(3):495-502. PubMed ID: 806606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of biological effects of bromodeoxyuridine by deoxycytidine: correlation with decreased incorporation of bromodeoxyuridine into DNA.
    Horn D; Davidson RL
    Somatic Cell Genet; 1976 Sep; 2(5):469-81. PubMed ID: 1027154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of radioactively labelled concanavalin A and wheat germ agglutinin to normal and virus-transformed cells.
    Ozanne B; Sambrook J
    Nat New Biol; 1971 Aug; 232(31):156-60. PubMed ID: 4328427
    [No Abstract]   [Full Text] [Related]  

  • 27. The effects of 5-bromodeoxyuridine on cyclic AMP levels and cytoskeletal organization in malignant melanoma cells.
    Giotta GJ; Brunson KW; Lotan R
    Cell Biol Int Rep; 1980 Jan; 4(1):105-16. PubMed ID: 6248251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoplastic transformation in vitro of a clone of adult liver epithelial cells into differentiated hepatoma-like cells under conditions of nutritional stress.
    Borek C
    Proc Natl Acad Sci U S A; 1972 Apr; 69(4):956-9. PubMed ID: 4337248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of lectin-induced lymphocyte activation by 2-cyclohexene-1-one: analysis of DNA synthesis in individual cells by BUdR quenching of Hoechst 33258.
    Wedner HJ; Bahn G; Gordon LK; Fischman CM
    Int J Immunopharmacol; 1985; 7(1):25-30. PubMed ID: 2581906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface-specific characteristics of a contact-inhibited cell line containing the SV40 viral genome.
    Pollack RE; Burger MM
    Proc Natl Acad Sci U S A; 1969 Apr; 62(4):1074-6. PubMed ID: 4307873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of bromodeoxyuridine in malignant and normal cells following therapy: relationship to complications.
    Morstyn G; Kinsella T; Hsu SM; Russo A; Gratzner H; Mitchell J
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1441-5. PubMed ID: 6469767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decrease in TTP pools mediated by 5-bromo-2'-deoxyuridine exposure in a human glioblastoma cell line.
    Shewach DS; Ellero J; Mancini WR; Ensminger WD
    Biochem Pharmacol; 1992 Apr; 43(7):1579-85. PubMed ID: 1567479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell kinetics studies of human brain tumors by in vitro labeling using anti-BUdR monoclonal antibody.
    Nishizaki T; Orita T; Saiki M; Furutani Y; Aoki H
    J Neurosurg; 1988 Sep; 69(3):371-4. PubMed ID: 3404235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differing sensitivity to fluorescent light in Chinese hamster cells containing equally incorporated quantities of BUdR versus IUdR.
    Mitchell JB; Morstyn G; Russo A; Kinsella TJ; Fornace A; McPherson S; Glatstein E
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1447-51. PubMed ID: 6469768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the iodinated surface membrane proteins and concanavalin A agglutination of transformed Syrian hamster cells.
    Clarke SM; Fink LM
    Biochim Biophys Acta; 1977 Jan; 464(2):433-41. PubMed ID: 188476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of malignancy and differentiation in melanotic melanoma cells.
    Silagi S; Bruce SA
    Proc Natl Acad Sci U S A; 1970 May; 66(1):72-8. PubMed ID: 4921328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-bromodeoxyuridine (BUdR) quenching of acridine orange fluorescence distinguishes cycling and non-cycling normal and malignant bone marrow cells in vitro.
    Maddox AM; Johnson DA; Keating MJ
    Leuk Res; 1989; 13(9):781-90. PubMed ID: 2796384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total substitution of bromodeoxyuridine for thymidine in the DNA of a bromodeoxyuridine-dependent cell line.
    Bick MD; Davidson RL
    Proc Natl Acad Sci U S A; 1974 May; 71(5):2082-6. PubMed ID: 4525473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoradiographic analysis of effects of 5-bromodeoxyuridine on neurogenesis in the chick embryo spinal cord.
    Bannigan JG
    Brain Res; 1987 Dec; 433(2):161-70. PubMed ID: 3690329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential response of adherent and unanchored melanoma cells to bromodeoxyuridine evidenced by specific lectin-binding protein changes.
    Rieber M; Rieber MS; Urbina C; Lira R
    Int J Cancer; 1989 May; 43(5):841-4. PubMed ID: 2714888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.